Table 4.
Preventing extubation failures | Risk ratio [95% CI] | NNT [95% CI] |
---|---|---|
NCPAP vs. Head-Box | 0.59 [0.48–0.72] | 6 [3–9] |
NCPAP vs. nHF | 1.11 [0.84–1.47] | – |
Methylxanthines | 0.48 [0.32–0.71] | 4 [2–7] |
DOXAPRAM | 0.80 [0.22–2.97] | – |
NIPPV vs. NCPAP | 0.70 [0.60–0.81] | 8 [5–13] |
NS-NIPPV or Bi-PAP vs. NCPAP | 064 [0.44–0.95] | 8 [4–50] |
SNIPPV vs. NCPAP | 0.25 [0.15–041] | 4 [2–5] |
NS-NIPPV or sNIPPV vs. NCPAP | 0.28 [0.18–043] | 4 [2–5] |
NS-NIPPV, non-synchronized NIPPV; sNIPPV, synchronized NIPPV; nHF, High flow nasal cannula. Ferguson et al. (75).